RFK Jr. Grants Access to Six Unproven Peptides, Overruling FDA

RFK Jr. Grants Access to Six Unproven Peptides, Overruling FDA

Audio narration · Coming soon

This decision comes after RFK Jr. unilaterally granted access to six peptides popular with MAHA, placing them under an 'enforcement discretion policy.' The move overrules the FDA's stance on these unproven peptides, signaling a significant regulatory shift.

Why this matters

PRISM scored this story 55/100 for interest.

Originally published by arstechnica